Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,365 shares at $2.34 ($3K) on 2022-11-29, disclosed to the SEC on 2022-12-23.
Scheduled purchase ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.53 | 65 | $164 | 5.1% |
| 2 | $2.54 | 65 | $165 | 5.1% |
| 3 | $2.44 | 65 | $159 | 4.9% |
| 4 | $2.42 | 65 | $157 | 4.9% |
| 5 | $2.45 | 65 | $159 | 4.9% |
| 6 | $2.42 | 65 |
| $157 |
| 4.9% |
| 7 | $2.37 | 65 | $154 | 4.8% |
| 8 | $2.37 | 65 | $154 | 4.8% |
| 9 | $2.32 | 65 | $151 | 4.7% |
| 10 | $2.32 | 65 | $151 | 4.7% |
| 11 | $2.35 | 65 | $153 | 4.7% |
| 12 | $2.31 | 65 | $150 | 4.6% |
| 13 | $2.29 | 65 | $149 | 4.6% |
| 14 | $2.27 | 65 | $148 | 4.6% |
| 15 | $2.38 | 65 | $155 | 4.8% |
| 16 | $2.37 | 65 | $154 | 4.8% |
| 17 | $2.29 | 65 | $149 | 4.6% |
| 18 | $2.31 | 65 | $150 | 4.6% |
| 19 | $2.37 | 65 | $154 | 4.8% |
| 20 | $2.34 | 65 | $152 | 4.7% |
| 21 | $2.32 | 65 | $151 | 4.7% |
| Total | $2.37 avg | 1,365 | $3K | 100% |
| Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |
| CPIX | BUY | 2022-08-19 | $5K | — | Filing → |